IP Library Granted Patent US 10,251,924
Granted Patent B2
US 10,251,924 · App. 14/036,097 · Granted Apr 9, 2019

Compositions containing myristica fragrans

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,251,924
App. No.
14/036,097
Granted
Apr 9, 2019
Kind
B2
Abstract

Compositions as nutritional supplements comprising extracts of Myristica fragrans for improving exercise performance and for promoting weight loss are disclosed. The compositions may contain, and be standardized to, myristicin and may be administered prior to physical exercise.

Claims (21)

1. A method for improving the efficacy of a composition administered prior to the commencement of exercise for improving exercise performance, the method comprising administering to an individual a composition comprising from 50 to 150 mg of an extract of Myristica fragrans , which extract comprises about 10 ug to 10 mg of myristicin, an extract of Coffea canephora extract, caffeine anhydrous, raspberry ketone, Salvia officinalis powder, an extract of Ecklonia cava , and an extract of Pausinystalia yohimbe , prior to commencement of exercise.

2. The method of claim 1 , wherein the composition is taken by the individual between about 60 minutes to about 30 minutes before commencement of exercise.

3. The method of claim 1 , wherein the composition comprises 50 mg of an extract of Myristica fragrans , 400 mg of Coffea canephora extract, 80 mg of caffeine anhydrous, 50 mg of raspberry ketone, 50 mg of Salvia officinalis powder, 18 mg of Ecklonia cava extract, and 8.5 mg of Pausinystalia yohimbe extract.

4. The method of claim 3 , wherein the improvement is at least one of: an increase in thermogenic response, an increase in energy, and an increase in focus.

5. A method for promoting weight loss in a subject in need thereof, the method comprising: administering to a subject a composition comprising [from 50 to 150 mg of] an extract of Myristica fragrans , which extract comprises about 10 ug to 10 mg of myristicin, an extract of Coffea canephora extract, caffeine anhydrous, raspberry ketone, Salvia officinalis powder, an extract of Ecklonia cava , and an extract of Pausinystalia yohimbe.

6. The method of claim 5 , wherein the composition is taken by the individual between about 60 minutes to about 30 minutes before commencement of exercise.

7. The method of claim 5 or 6 , wherein the weight loss is supported by an increase in at least one of: an increase in thermogenic response and an increase in energy.

8. The method of claim 1 , wherein the composition comprises from 50 to 150 mg of an extract of Myristica fragrans , from 200 to 600 mg of Coffea canephora extract, from 80 to 250 mg of caffeine anhydrous, from 25 to 125 mg of raspberry ketone, from 10to 150 mg of Salvia officinalis powder, from 7.5to 50 mg of Ecklonia cava extract, and from 5 to 20 mg of Pausinystalia yohimbe extract.

9. The method of claim 1 , wherein the composition comprises 100 mg of an extract of Myristica fragrans , 400 mg of Coffea canephora extract, 80 mg of caffeine anhydrous, 50 mg of raspberry ketone, 50 mg of Salvia officinalis powder, 18 mg of Ecklonia cava extract, and 8.5 mg of Pausinystalia yohimbe extract.

10. The method of claim 1 , wherein the composition comprises 150 mg of an extract of Myristica fragrans , 400 mg of Coffea canephora extract, 120 mg of caffeine anhydrous, 50 mg of raspberry ketone, 75 mg of Salvia officinalis powder, 18 mg of Ecklonia cava extract, and 8.5 mg of Pausinystalia yohimbe extract.

11. The method of claim 1 , wherein the composition comprises 100 mg of an extract of Myristica fragrans , 400 mg of Coffea canephora extract, 135 mg of caffeine anhydrous, 50 mg of raspberry ketone, 75 mg of Salvia officinalis powder, 18 mg of Ecklonia cava extract, and 8.5 mg of Pausinystalia yohimbe extract.

12. The method of claim 1 , wherein the composition comprises 100 mg of an extract of Myristica fragrans , 400 mg of Coffea canephora extract, 135 mg of caffeine anhydrous, 50 mg of raspberry ketone, 75 mg of Salvia officinalis powder, 36 mg of Ecklonia cava extract, and 8.5 mg of Pausinystalia yohimbe extract.

13. The method of claim 1 , wherein the composition comprises 150 mg of an extract of Myristica fragrans , 120 mg of caffeine anhydrous, and 75 mg of Salvia officinalis powder.

14. The method of claim 1 , wherein the composition is in the form of a capsule.

15. The method of claim 5 , wherein the composition is in the form of a capsule.

16. The method of claim 8 , wherein the composition is in the form of a capsule.

17. The method of claim 9 , wherein the composition is in the form of a capsule.

18. The method of claim 10 , wherein the composition is in the form of a capsule.

19. The method of claim 11 , wherein the composition is in the form of a capsule.

20. The method of claim 12 , wherein the composition is in the form of a capsule.

21. The method of claim 13 , wherein the composition is in the form of a capsule.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded May 29, 2026
From: ROYAL BANK OF CANADA
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 075647/0267 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SERIAL NUMBER OF PATENT NUMBER 7,645,812 TO 7,465,812 PREVIOUSLY RECORDED AT REEL: 059662 FRAME: 0958. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 26, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059793/0777 →
SECURITY INTEREST Recorded Apr 21, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059662/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2013
From: BASHIR, RAZA; APONG, PHILIP; LYTVYN, ANNA
To: NORTHERN INNOVATIONS HOLDING CORP
Reel/Frame 031546/0258 →